Über uns
Antonia Gabriel
CEO/CSO/Lead Clinical Studies
Dr. sc. ETH Microbiology and Immunology
antonia@evax.ch
Fabia Canonica
Head of Biologics Development & Manufacturing
Dr. sc. ETH in Molecular Biology and Biophysics
fabia@evax.ch
Fadi Jebbawi
Head Immunoassays and Biomarkers
Dr. rer. nat. in Immunology, Molecular and Cellular Biology
fadi@evax.ch
Juwela Lam
Research Associate and Laboratory Officer
M. Sc. ETH in Food Science and "Human Health, Nutrition and Environment"
juwela@evax.ch
Consultants
Prof. Dr. Med. Thomas M. Kündig
-
Chair of Dermatology and Venereology at the Medical Faculty of the University of Zurich
-
Director of the Dermatological Clinic at the University Hospital Zurich
Prof. Dr. phil. nat. Christian Surber
-
Professor of Dermatopharmacology and Hospital Pharmacy
-
i.a. expert in drug delivery from topical formulations, topical delivery vehicle design, topical bioavailability / bioequivalence testing, topical pharmacotherapy of barrier function impairment (dry skin, atopic dermatitis, psoriasis) and solar damage (skin cancer)
Founders
Dr. Antonia Gabriel (Fettelschoss)
-
Inventor and founder of Evax AG
-
Studied human biology at the University of Zurich and graduated with a Master of Science degree in 2008. She then started directly with a doctorate in immunology at ETH Zurich and graduated in 2011
-
During her doctorate, she worked part-time at the Clinical Trials Center Zurich and completed internships at the Swiss Institute for Allergy and Asthma (SIAF) and the Swiss Tropical Institute (TPH)
-
Certificate of Advanced Studies in Clinical Trial Management
-
After completing her doctorate, she worked as a scientist at Vifor Pharma and Saiba GmbH.
-
In addition to her work at Evax, she works as a group leader at the University of Zurich / University Hospital Zurich in the field of immunology
-
She started riding at the age of 5 and got to know Icelandic horses at the age of 12 and remains loyal to them to this day. Her family has since owned Icelandic horses, all of which were / are imports from Iceland and were / are affected by sweet itch
Prof. Martin Bachmann
-
Co-inventor and co-founder of Evax AG
-
Founder of Saiba GmbH
-
Author of more than 200 scientific publications
-
Over 20 years of experience in the field of immunology and more than 10 years of experience in the biotech industry
-
Leading scientist in the field of active immunotherapy for chronic diseases
-
Inventor of over 40 patents in the vaccine field
-
Professor at Oxford, visiting professor at the University of Zurich and Professor of Immunology at the University of Bern
We collaborate with
Career
We are a spin-off company of the University of Zurich, transferring human standards of care into horses. Our research team develops therapeutic vaccines to treat chronic diseases, allergies and respiratory diseases. Our vision is to address diseases in horses with modern research to contribute to the growing knowledge in the pharmaceutical industry.
We offer a varied and interesting work in a young team in modern research laboratories in the Wagiareal in Schlieren with attractive employment conditions and various opportunities. In our group, self-initiative and responsibility are promoted and your flexible working hours support an eligible work-life balance.